14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Cellectis S.A. Stock Forecast

NASDAQ:CLLS BUY SELL

$3.69 (-2.38%)

Volume: 37.823k

Closed: May 23, 2022

Hollow Logo Score: -0.854

Cellectis S.A. Stock Forecast

BUY SELL NASDAQ:CLLS
$3.69 (-2.38%)

Volume: 37.823k

Closed: May 23, 2022

Score Hollow Logo -0.854

Cellectis S.A. Stock Price (Quote) NASDAQ:CLLS

$3.69 ( -2.38% ) Monday, 23rd May 2022

Range Low Price High Price Comment
30 days $2.85 $4.16 Monday, 23rd May 2022 CLLS stock ended at $3.69. This is 2.38% less than the trading day before Friday, 20th May 2022. During the day the stock fluctuated 4.97% from a day low at $3.62 to a day high of $3.80.
90 days $2.85 $5.04
52 weeks $2.85 $16.53

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2022-05-23 $3.78 $3.80 $3.62 $3.69 37 823
2022-05-20 $3.89 $3.89 $3.72 $3.78 71 947
2022-05-19 $3.55 $3.97 $3.54 $3.93 229 345
2022-05-18 $3.56 $3.57 $3.25 $3.27 172 196
2022-05-17 $3.46 $3.53 $3.38 $3.48 114 868
2022-05-16 $3.19 $3.21 $3.10 $3.14 56 892
2022-05-13 $2.93 $3.25 $2.93 $3.17 140 392
2022-05-12 $2.87 $3.07 $2.87 $3.05 75 620
2022-05-11 $3.10 $3.12 $2.85 $2.90 191 837
2022-05-10 $3.00 $3.13 $3.00 $3.11 86 738
2022-05-09 $3.20 $3.27 $3.04 $3.05 146 589
2022-05-06 $3.48 $3.52 $3.35 $3.44 391 722
2022-05-05 $3.74 $4.03 $3.74 $3.83 130 705
2022-05-04 $3.60 $3.89 $3.50 $3.81 238 268
2022-05-03 $3.70 $3.86 $3.68 $3.82 80 709
2022-05-02 $3.51 $3.72 $3.51 $3.58 63 419
2022-04-29 $3.60 $3.74 $3.50 $3.50 113 935
2022-04-28 $3.78 $3.80 $3.59 $3.64 195 916
2022-04-27 $3.59 $4.16 $3.58 $3.83 453 465
2022-04-26 $3.73 $3.77 $3.62 $3.70 258 762
2022-04-25 $3.75 $3.83 $3.69 $3.80 87 031
2022-04-22 $3.90 $4.01 $3.77 $3.78 74 600
2022-04-21 $4.13 $4.17 $3.95 $3.98 274 000
2022-04-20 $4.00 $4.05 $3.95 $3.97 75 900
2022-04-19 $4.01 $4.12 $3.95 $4.00 126 800
2022-04-18 $4.11 $4.12 $4.04 $4.12 83 800
2022-04-14 $4.25 $4.25 $4.12 $4.12 17 964
2022-04-13 $4.11 $4.34 $4.11 $4.31 63 658
2022-04-12 $4.26 $4.37 $4.15 $4.19 111 638
2022-04-11 $4.30 $4.43 $4.25 $4.32 95 442
2022-04-08 $4.56 $4.57 $4.36 $4.36 47 726
2022-04-07 $4.53 $4.64 $4.44 $4.58 147 800
2022-04-06 $4.55 $4.60 $4.40 $4.50 110 700
2022-04-05 $4.90 $4.94 $4.62 $4.67 186 400
2022-04-04 $4.81 $5.04 $4.78 $4.93 181 500
2022-04-01 $4.56 $4.93 $4.51 $4.84 357 604
2022-03-31 $4.50 $4.65 $4.45 $4.56 518 289
2022-03-30 $4.59 $4.68 $4.46 $4.50 87 774
2022-03-29 $4.32 $4.67 $4.32 $4.62 132 800
2022-03-28 $4.41 $4.47 $4.20 $4.27 108 300
2022-03-25 $4.56 $4.56 $4.34 $4.39 103 200
2022-03-24 $4.69 $4.73 $4.51 $4.64 173 700
2022-03-23 $4.15 $4.41 $4.11 $4.34 220 600
2022-03-22 $4.04 $4.31 $4.04 $4.25 223 862
2022-03-21 $4.19 $4.21 $4.00 $4.03 330 005
2022-03-18 $4.51 $4.71 $4.05 $4.06 883 387
2022-03-17 $4.54 $4.74 $4.54 $4.66 150 000
2022-03-16 $4.43 $4.59 $4.31 $4.57 334 100
2022-03-15 $4.14 $4.31 $4.07 $4.24 115 400
2022-03-14 $4.27 $4.35 $4.06 $4.09 198 800

About Cellectis S.A.

Cellectis SA Cellectis S.A., a gene-editing company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. The company’s products also include UCART1... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT